Business

Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality

Pharmacy Quality Alliance award underscores sustained excellence in care delivery, medication adherence and pharmacy excellence for seniorsORANGE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). Out of 613 eligible contracts, only 1.6% achieved recognition, highlighting the significance of this award. The recognition mar

articleAlignment Healthcare, Inc.May 14, 20263/company/alignment-healthcare-llc/news/alignment-health-plan-recognized-as-one-of-four-medicare-advantage-prescription-drug-plans-in-the-us-for-2026-excellence-in-quality
Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality

About this update from Alignment Healthcare, Inc.

[{"type":"image","alt":"Alignment Healthcare USA, LLC","displaySize":"","headline":null,"caption":"Alignment Healthcare USA, LLC","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":80,"url":"https://media.zenfs.com/en/globenewswire.com/c774917223eaf55f8197a312cc5bda8a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2OYZIadeATP.oe9lGm4TKg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMg--/https://media.zenfs.com/en/globenewswire.com/c774917223eaf55f8197a312cc5bda8a","width":300,"height":80},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/2OYZIadeATP.oe9lGm4TKg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMg--/https://media.zenfs.com/en/globenewswire.com/c774917223eaf55f8197a312cc5bda8a","width":300,"height":80}},"lazy":false},{"type":"text","content":"Pharmacy Quality Alliance award underscores sustained excellence in care delivery, medication adherence and pharmacy excellence for seniors","length":139,"tagName":"p"},{"type":"text","content":"ORANGE, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been recognized for excellence in quality for its Medicare Advantage prescription drug (MAPD) plan by the Pharmacy Quality Alliance (PQA). Out of 613 eligible contracts, only 1.6% achieved recognition, highlighting the significance of this award.","length":341,"tagName":"p"},{"type":"text","content":"The recognition marks the seventh time Alignment has received this award, reinforcing its dedication to providing the best care for seniors. The PQA has measured medication safety for the Centers for Medicare and Medicaid Services (CMS) since 2006, ensuring medication safety, adherence and appropriate use.","length":307,"tagName":"p"},{"type":"text","content":"“We are incredibly honored that Alignment Health Plan has once again been recognized by PQA as a national leader in medication safety and adherence,” said Dawn Maroney, CEO, Alignment Health Plan. “Being one of only four MAPD plans to earn the 2026 Excellence in Quality Award reinforces our mission to put seniors first. By combining sophisticated data analytics with personalized care, we continue to bridge care gaps and empower our members to live their healthiest, most vibrant lives.”","length":490,"tagName":"p"},{"type":"text","content":"The 2026 PQA Laura Cranston Excellence in Quality Award goes to MAPDs with at least a 4.5-star Part D sum...

More updates from Alignment Healthcare, Inc.

Alignment HealthcareHealth Planmedication adherencePQAAlignment Health PlanMedicare AdvantageQuality AwardPharmacy Quality AllianceHealth